Growth Metrics

Dare Bioscience (DARE) Receivables - Other (2017 - 2025)

Dare Bioscience's Receivables - Other history spans 7 years, with the latest figure at $573061.0 for Q4 2025.

  • For Q4 2025, Receivables - Other rose 149.18% year-over-year to $573061.0; the TTM value through Dec 2025 reached $573061.0, up 149.18%, while the annual FY2025 figure was $573061.0, 149.18% up from the prior year.
  • Receivables - Other reached $573061.0 in Q4 2025 per DARE's latest filing, up from $369157.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $3.0 million in Q2 2021 to a low of $105234.0 in Q1 2025.
  • Average Receivables - Other over 5 years is $1.1 million, with a median of $925692.5 recorded in 2023.
  • Peak YoY movement for Receivables - Other: skyrocketed 1568.48% in 2021, then tumbled 92.41% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $1.1 million in 2021, then soared by 48.71% to $1.7 million in 2022, then plummeted by 44.27% to $949211.0 in 2023, then tumbled by 75.77% to $229982.0 in 2024, then soared by 149.18% to $573061.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Receivables - Other are $573061.0 (Q4 2025), $369157.0 (Q3 2025), and $188116.0 (Q2 2025).